Hai Zou

2.0k total citations
76 papers, 1.6k citations indexed

About

Hai Zou is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Hai Zou has authored 76 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 18 papers in Epidemiology and 11 papers in Oncology. Recurrent topics in Hai Zou's work include Liver Disease Diagnosis and Treatment (10 papers), Cancer Research and Treatments (7 papers) and Virus-based gene therapy research (6 papers). Hai Zou is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Cancer Research and Treatments (7 papers) and Virus-based gene therapy research (6 papers). Hai Zou collaborates with scholars based in China, United States and United Kingdom. Hai Zou's co-authors include Xiaozhou Mou, Yahui Ding, Dongsheng Huang, Ming‐Hua Zheng, Wenjun Wang, Xiaochen Dong, Hui Li, Xuejiao Song, Nan Yang and Jinjun Shao and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hai Zou

71 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hai Zou China	21	546	299	201	199	189	76	1.6k
Qing Peng China	24	696 1.3×	274 0.9×	114 0.6×	138 0.7×	220 1.2×	109	1.8k
Mengqi Zhu China	22	650 1.2×	333 1.1×	159 0.8×	126 0.6×	149 0.8×	75	1.5k
Ziyu Wang China	27	649 1.2×	294 1.0×	164 0.8×	90 0.5×	254 1.3×	139	2.0k
Zhiying Yang China	23	533 1.0×	256 0.9×	277 1.4×	100 0.5×	502 2.7×	104	1.9k
Wenjing Yu China	24	877 1.6×	182 0.6×	268 1.3×	74 0.4×	305 1.6×	73	2.2k
Toshihiko Matsumoto Japan	21	448 0.8×	242 0.8×	60 0.3×	232 1.2×	211 1.1×	82	1.4k
Casimiro Luca Gigliotti Italy	26	573 1.0×	232 0.8×	401 2.0×	71 0.4×	241 1.3×	53	1.8k
Zhao Zhang China	23	723 1.3×	152 0.5×	78 0.4×	139 0.7×	203 1.1×	73	1.4k
Xingxin Wu China	26	628 1.2×	219 0.7×	531 2.6×	518 2.6×	292 1.5×	69	2.2k
Tianhui Liu China	22	627 1.1×	427 1.4×	311 1.5×	136 0.7×	114 0.6×	69	1.6k

Countries citing papers authored by Hai Zou

Since Specialization

Citations

This map shows the geographic impact of Hai Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai Zou more than expected).

Fields of papers citing papers by Hai Zou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai Zou. The network helps show where Hai Zou may publish in the future.

Co-authorship network of co-authors of Hai Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Hai Zou. A scholar is included among the top collaborators of Hai Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai Zou. Hai Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Yuxuan, Yuxuan Liu, Junjia He, et al.. (2025). Cholesterol surface-modified oncolytic adenovirus enriched with apolipoprotein E penetrates the blood-brain barrier to target glioblastoma immunotherapy. Materials Today Bio. 35. 102319–102319.

Ge, Tong, Yuxuan Chen, Yuxuan Liu, et al.. (2025). ApoE-Corona oncolytic adenovirus nanoparticles enable blood–brain barrier penetration for glioblastoma immunotherapy. Journal of Controlled Release. 387. 114255–114255.

Li, Yishu, Shao Su, Yuanhao Zhou, et al.. (2025). Oral administration of Folium Artemisiae Argyi-derived exosome-like nanovesicles can improve ulcerative colitis by regulating intestinal microorganisms. Phytomedicine. 137. 156376–156376. 15 indexed citations

Wang, Yuanyuan, Qingyuan Wu, Yishu Li, et al.. (2025). Honeysuckle‐Derived Nanovesicles Regulate Gut Microbiota for the Treatment of Inflammatory Bowel Disease. Advanced Science. 12(45). e05208–e05208. 1 indexed citations

Zheng, Wenjie, Jingxing Si, Xue Yang, et al.. (2024). Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy. Acta Biomaterialia. 179. 243–255. 10 indexed citations

Li, Jie‐Ting, Peier Chen, Lihan Shen, et al.. (2024). Oral probiotic extracellular vesicle therapy mitigates Influenza A Virus infection via blunting IL-17 signaling. Bioactive Materials. 45. 401–416. 13 indexed citations

Wang, Shibing, Xue Yang, Ketao Jin, et al.. (2024). An Engineered Self-biomineralized Oncolytic Adenovirus Induces Effective Antitumor Immunity and Synergizes With Immune Checkpoint Blockade. Cancer Immunology Research. 12(11). 1640–1654. 2 indexed citations

Zou, Hai, et al.. (2023). An open, retrospective study on the duration of virus shedding for Shanghai patients infected with SARS‐CoV‐2 omicron variants. Health Science Reports. 6(2). e1088–e1088. 1 indexed citations

Ma, Ying‐Yu, Jingxing Si, Xiaozhou Mou, & Hai Zou. (2023). LY6E level associated with smoking as risk for lung cancer patients susceptible to COVID-19. SHILAP Revista de lepidopterología. 1 indexed citations

10.

Zou, Hai. (2023). Giant J waves in a critically ill patient with COVID‐19 pneumonia. Health Science Reports. 6(5). e1253–e1253. 1 indexed citations

11.

Zhao, Xin, Luo‐Qin Fu, Hai Zou, et al.. (2023). Optogenetic engineered umbilical cord MSC-derived exosomes for remodeling of the immune microenvironment in diabetic wounds and the promotion of tissue repair. Journal of Nanobiotechnology. 21(1). 176–176. 59 indexed citations

12.

Cao, Changyu, Hai Zou, Nan Yang, et al.. (2021). Fe₃O₄/Ag/Bi₂MoO₆ Photoactivatable Nanozyme for Self‐Replenishing and Sustainable Cascaded Nanocatalytic Cancer Therapy. Advanced Materials. 33(52). e2106996–e2106996. 215 indexed citations

13.

Zou, Hai, et al.. (2020). Pulmonary fibrosis in critically ill patients with novel coronavirus pneumonia during the convalescent stage and a proposal for early intervention. Acta Pharmacologica Sinica. 42(8). 1376–1378. 13 indexed citations

14.

Lei, Kefeng, et al.. (2019). Breast cancer prognosis is better in patients who develop subsequent metachronous thyroid cancer. PLoS ONE. 14(5). e0215948–e0215948. 10 indexed citations

15.

Zou, Hai, et al.. (2017). Trimetazidine in conditions other than coronary disease, old drug, new tricks?. International Journal of Cardiology. 234. 1–6. 13 indexed citations

16.

Xin, Jun, et al.. (2016). Hypokalemic myopathy in primary aldosteronism: A case report. Experimental and Therapeutic Medicine. 12(6). 4064–4066. 5 indexed citations

17.

Zou, Hai, et al.. (2016). Toll-like receptors in hepatocellular carcinoma: potential novel targets for pharmacological intervention. Expert Opinion on Therapeutic Targets. 20(9). 1127–1135. 15 indexed citations

18.

Zhu, Xingxing, et al.. (2016). Silibinin: a potential old drug for cancer therapy. Expert Review of Clinical Pharmacology. 9(10). 1323–1330. 52 indexed citations

19.

Wu, Shengjie, Gui‐Qi Zhu, Bozhi Ye, et al.. (2015). Association Between Sex-Specific Serum Uric Acid and Non-Alcoholic Fatty Liver Disease in Chinese Adults. Medicine. 94(17). e802–e802. 56 indexed citations

20.

Wu, Shengjie, Hai Zou, Gui‐Qi Zhu, et al.. (2015). Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease. Medicine. 94(19). e842–e842. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact